| Code: MTA8442 | Publication Date: Sep 2025 |
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Neurology Devices Market.
This growth is attributed mainly to the rising prevalence of neurological disorders, advancements in neurostimulation technologies, and demand for minimally invasive procedures to diagnose, monitor, and treat brain disorders.
The neurology devices market is undergoing a dynamic transformation, and current trends reflect the shift toward patient-centered and precision-based solutions. The market is seeing strong uptake of minimally invasive neuro-intervention devices, neurostimulation systems and high-definition brain imaging technology. Integration with digital platforms is also a major trend tied to enhancing clinical outcomes.
The market is also witnessing a rise in wearable EEG monitors, real-time neural activity monitors, and AI-assisted diagnostic devices. Trends also include an increase in collaborative research for developing brain-computer interfaces and miniaturized devices for home-based neurological care.
The neurology devices market is experiencing notable developments driven by innovation in product design and functionality. Companies are launching next-generation neuromodulation devices that will be wireless and have a closed-loop feedback system that enhances patient adaptability with condition-specific treatment.
Also, collaboration between device manufacturers and software engineers are facilitating cloud computing and data analytics capabilities leading to more informed decisions in clinical neurology. Implantable neuro devices and robotic-assisted neurosurgical instruments are facilitating treatments for many complex brain problems.
Below is a comprehensive list of the leading market players driving growth in this sector:
| Company Name | Medtronic |
| Establishment Year | 1949 |
| Headquarter | Dublin, Ireland |
| Official Website | Click here |
Medtronic offers a wide range of neuromodulation and neurovascular devices used in treating movement disorders and brain aneurysms.
| Company Name | Boston Scientific Corporation |
| Establishment Year | 1979 |
| Headquarter | Marlborough, United States |
| Official Website | Click here |
Boston Scientific specializes in deep brain stimulation systems and spinal cord stimulators for neurological disorder management.
| Company Name | Stryker Corporation |
| Establishment Year | 1941 |
| Headquarter | Kalamazoo, United States |
| Official Website | Click here |
Stryker provides advanced neurosurgical and neurovascular solutions, including aneurysm clips and stroke treatment devices.
| Company Name | Abbott Laboratories |
| Establishment Year | 1888 |
| Headquarter | Illinois, United States |
| Official Website | Click here |
Abbott develops neuromodulation and electrophysiology systems for chronic pain, Parkinson’s, and epilepsy patients.
| Company Name | Natus Medical Incorporated |
| Establishment Year | 1987 |
| Headquarter | Pleasanton, United States |
| Official Website | Click here |
Natus offers neurodiagnostic and monitoring devices, including EEG, EMG, and sleep diagnostic systems.
| Company Name | Penumbra Inc. |
| Establishment Year | 2004 |
| Headquarter | Alameda, United States |
| Official Website | Click here |
Penumbra designs and markets innovative devices for stroke intervention and neurovascular conditions.
| Company Name | Integra LifeSciences |
| Establishment Year | 1989 |
| Headquarter | Princeton, United States |
| Official Website | Click here |
Integra offers a portfolio of neurosurgical instruments, dural repair products, and neuro-critical care solutions.
| Company Name | NeuroPace Inc. |
| Establishment Year | 1997 |
| Headquarter | Mountain View, United States |
| Official Website | Click here |
NeuroPace is known for its responsive neurostimulation system (RNS) for the treatment of refractory epilepsy.
| Company Name | LivaNova PLC |
| Establishment Year | 2015 |
| Headquarter | London, United Kingdom |
| Official Website | Click here |
LivaNova provides neuromodulation systems, including vagus nerve stimulation devices for epilepsy and depression.
| Company Name | Cyberonics (now part of LivaNova) |
| Establishment Year | 1987 |
| Headquarter | Houston, United States |
| Official Website | Click here |
Cyberonics developed pioneering VNS therapies used widely in neurological device applications before merging with LivaNova.